As Figure 7 illustrates, SNAP91, NEFM, and ELAVL4 were all involved in AD pathways; ENO2 was involved in a cancer pathway and the PI3K–AKT pathway; the latter pathway has also been reported in AD (Wang C. et al., 2020). Here, ENO2 is linked to cancer.